TRACIE HAMPTON: Open Payments
NPI 1841666237 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 27 payments from 11 companies in 2025. Trend: 2023 $898 · 2024 $518 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $163 |
| Alkermes, Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: ARISTADA, CAPLYTA, REXULTI, ABILIFY MAINTENA, Qelbree, SPRAVATO, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
